Home/Filings/4/0001209191-18-055699
4//SEC Filing

Montreux Equity Partners IV, L.P. 4

Accession 0001209191-18-055699

CIK 0001459839other

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 4:49 PM ET

Size

43.2 KB

Accession

0001209191-18-055699

Insider Transaction Report

Form 4
Period: 2018-10-19
Transactions
  • Conversion

    Series 6 Preferred Stock

    2018-10-19563,9260 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (597,071 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-1948,9500 total(indirect: By LLC)
    Common Stock (51,827 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-1927,4090 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (27,409 underlying)
  • Conversion

    Common Stock

    2018-10-19+1,102,9151,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+597,0711,699,986 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+27,4091,727,395 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+78,56478,564 total(indirect: By LLC)
  • Sale

    Series 5 Preferred Stock

    2018-10-19$15.00/sh9,397$140,9551,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (9,397 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-1978,5640 total(indirect: By LLC)
    Common Stock (78,564 underlying)
  • Conversion

    Common Stock

    2018-10-19+171,929171,929 total(indirect: By LLC)
  • Exercise of In-Money

    Series 5 Preferred Stock

    2018-10-19+15,4961,112,312 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Common Stock (15,496 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-191,102,9150 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (1,102,915 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-19171,9290 total(indirect: By LLC)
    Common Stock (171,929 underlying)
  • Conversion

    Common Stock

    2018-10-19+51,827130,391 total(indirect: By LLC)
  • Exercise of In-Money

    Warrant (right to buy)

    2018-10-1915,4960 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Series 5 Preferred Stock (15,496 underlying)
Transactions
  • Conversion

    Common Stock

    2018-10-19+1,102,9151,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+51,827130,391 total(indirect: By LLC)
  • Conversion

    Common Stock

    2018-10-19+171,929171,929 total(indirect: By LLC)
  • Conversion

    Series 6 Preferred Stock

    2018-10-19563,9260 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (597,071 underlying)
  • Conversion

    Common Stock

    2018-10-19+78,56478,564 total(indirect: By LLC)
  • Conversion

    Series 5 Preferred Stock

    2018-10-191,102,9150 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (1,102,915 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-1927,4090 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (27,409 underlying)
  • Exercise of In-Money

    Series 5 Preferred Stock

    2018-10-19+15,4961,112,312 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Common Stock (15,496 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-1978,5640 total(indirect: By LLC)
    Common Stock (78,564 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-19171,9290 total(indirect: By LLC)
    Common Stock (171,929 underlying)
  • Conversion

    Common Stock

    2018-10-19+597,0711,699,986 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Exercise of In-Money

    Warrant (right to buy)

    2018-10-1915,4960 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Series 5 Preferred Stock (15,496 underlying)
  • Conversion

    Common Stock

    2018-10-19+27,4091,727,395 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Sale

    Series 5 Preferred Stock

    2018-10-19$15.00/sh9,397$140,9551,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (9,397 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-1948,9500 total(indirect: By LLC)
    Common Stock (51,827 underlying)
Transactions
  • Conversion

    Common Stock

    2018-10-19+171,929171,929 total(indirect: By LLC)
  • Conversion

    Common Stock

    2018-10-19+1,102,9151,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Series 7 Preferred Stock

    2018-10-19171,9290 total(indirect: By LLC)
    Common Stock (171,929 underlying)
  • Conversion

    Common Stock

    2018-10-19+597,0711,699,986 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Exercise of In-Money

    Series 5 Preferred Stock

    2018-10-19+15,4961,112,312 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Common Stock (15,496 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-1978,5640 total(indirect: By LLC)
    Common Stock (78,564 underlying)
  • Conversion

    Common Stock

    2018-10-19+78,56478,564 total(indirect: By LLC)
  • Conversion

    Common Stock

    2018-10-19+27,4091,727,395 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Series 5 Preferred Stock

    2018-10-191,102,9150 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (1,102,915 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-1948,9500 total(indirect: By LLC)
    Common Stock (51,827 underlying)
  • Conversion

    Common Stock

    2018-10-19+51,827130,391 total(indirect: By LLC)
  • Exercise of In-Money

    Warrant (right to buy)

    2018-10-1915,4960 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Series 5 Preferred Stock (15,496 underlying)
  • Sale

    Series 5 Preferred Stock

    2018-10-19$15.00/sh9,397$140,9551,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (9,397 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-19563,9260 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (597,071 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-1927,4090 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (27,409 underlying)
Transactions
  • Conversion

    Series 5 Preferred Stock

    2018-10-1978,5640 total(indirect: By LLC)
    Common Stock (78,564 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-1948,9500 total(indirect: By LLC)
    Common Stock (51,827 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-1927,4090 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (27,409 underlying)
  • Conversion

    Common Stock

    2018-10-19+78,56478,564 total(indirect: By LLC)
  • Conversion

    Common Stock

    2018-10-19+27,4091,727,395 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Exercise of In-Money

    Series 5 Preferred Stock

    2018-10-19+15,4961,112,312 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Common Stock (15,496 underlying)
  • Conversion

    Common Stock

    2018-10-19+1,102,9151,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Sale

    Series 5 Preferred Stock

    2018-10-19$15.00/sh9,397$140,9551,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (9,397 underlying)
  • Conversion

    Common Stock

    2018-10-19+597,0711,699,986 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+51,827130,391 total(indirect: By LLC)
  • Conversion

    Common Stock

    2018-10-19+171,929171,929 total(indirect: By LLC)
  • Exercise of In-Money

    Warrant (right to buy)

    2018-10-1915,4960 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Series 5 Preferred Stock (15,496 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-191,102,9150 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (1,102,915 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-19563,9260 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (597,071 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-19171,9290 total(indirect: By LLC)
    Common Stock (171,929 underlying)
Transactions
  • Conversion

    Common Stock

    2018-10-19+51,827130,391 total(indirect: By LLC)
  • Conversion

    Series 6 Preferred Stock

    2018-10-1948,9500 total(indirect: By LLC)
    Common Stock (51,827 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-19171,9290 total(indirect: By LLC)
    Common Stock (171,929 underlying)
  • Conversion

    Common Stock

    2018-10-19+1,102,9151,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+597,0711,699,986 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Exercise of In-Money

    Warrant (right to buy)

    2018-10-1915,4960 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Series 5 Preferred Stock (15,496 underlying)
  • Conversion

    Series 7 Preferred Stock

    2018-10-1927,4090 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (27,409 underlying)
  • Conversion

    Common Stock

    2018-10-19+27,4091,727,395 total(indirect: By Montreux Equity Partners IV, L.P.)
  • Conversion

    Common Stock

    2018-10-19+78,56478,564 total(indirect: By LLC)
  • Conversion

    Common Stock

    2018-10-19+171,929171,929 total(indirect: By LLC)
  • Exercise of In-Money

    Series 5 Preferred Stock

    2018-10-19+15,4961,112,312 total(indirect: By Montreux Equity Partners IV, L.P.)
    Exercise: $9.10Common Stock (15,496 underlying)
  • Sale

    Series 5 Preferred Stock

    2018-10-19$15.00/sh9,397$140,9551,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (9,397 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-191,102,9150 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (1,102,915 underlying)
  • Conversion

    Series 6 Preferred Stock

    2018-10-19563,9260 total(indirect: By Montreux Equity Partners IV, L.P.)
    Common Stock (597,071 underlying)
  • Conversion

    Series 5 Preferred Stock

    2018-10-1978,5640 total(indirect: By LLC)
    Common Stock (78,564 underlying)
Footnotes (5)
  • [F1]The Issuer's Series 5 Preferred Stock and Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
  • [F2]Montreux Equity Management IV, L.L.C. ("MEM IV LLC") is the general partner of each of Montreux Equity Partners IV, L.P., Montreux IV Associates, L.L.C and Montreux IV Associates IV, L.L.C. Daniel K. Turner III is the managing director of MEM IV LLC and may be deemed to have voting and investment power over the shares held by each of these entities. Mr. Turner disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest, if any.
  • [F3]The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
  • [F4]Shares subject to the warrant are immediately exercisable. The warrant will expire in connection with the closing of the Issuer's initial public offering.
  • [F5]Immediately prior to the closing of the Issuer's initial public offering, Montreux Equity Partners IV, L.P. exercised a warrant to purchase 15,496 shares of Series 5 Preferred Stock at an exercise price of $9.10 per share. The exercise price was paid on a net exercise cashless basis calculated using the Issuer's initial public offering price of $15.00, resulting in the Issuer withholding 9,397 of the warrant shares to pay the exercise price and issuing MEP the remaining 6,099 shares.

Issuer

SI-BONE, Inc.

CIK 0001459839

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0001456153

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:49 PM ET
Size
43.2 KB